Responses
Oncolytic and local immunotherapy
Original research
An engineered oncolytic vaccinia virus encoding a single-chain variable fragment against TIGIT induces effective antitumor immunity and synergizes with PD-1 or LAG-3 blockade
Compose a Response to This Article
Other responses
No responses have been published for this article.